These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday.
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) Maintained Hold at Argus.
CenterPoint Energy Inc. (NYSE: CNP) Cut to Neutral at Credit Suisse.
Chimera Investment Corporation (NYSE: CIM) Cut to Underperform at BofA/ML; Cut to Neutral at Credit Suisse.
Facebook, Inc. (NASDAQ: FB) Started as Hold with $38 target at Argus.
Heico Corporation (NYSE: HEI) Cut to Neutral at Credit Suisse.
Invesco Ltd. (NYSE: IVZ) Started as Buy with $28 target at Argus.
Onyx Pharmaceuticals (NASDAQ: ONXX) Raised to Outperform at R.W. Baird; Started as Buy at Deutsche Bank.
Quest Diagnostics Inc. (NYSE: DGX) Started as Hold at Canaccord Genuity.
Smart Balance, Inc. (NASDAQ: SMBL) Reiterated Buy and raised target to $10 at Canaccord Genuity.
TJX Companies Inc. (NYSE: TJX) Raised to Outperform at Wells Fargo.
Under Armour (NYSE: UA) Cut to Neutral at UBS.
Whole Foods Market (NASDAQ: WFM) Started as Buy at SunTrust.
Woodward Inc. (NASDAQ: WWD) Started as Outperform with $48 target at Credit Suisse.
If you enjoyed the top analyst upgrades and downgrades, you can join our free email newsletter that includes analyst summaries each morning sent right to your inbox. We also cover top issues such as IPOs, special financial exclusives, mergers and more. Sign up in the box below.
JON C. OGG